3.0 Credits - CME/CPE | Expires 1/15/2016
This activity is supported by an educational grant from Astellas Scientific and Medical Affairs, Inc.
Faculty
Cher Enderby, PharmD, BCPS, BCNSP
Transplant Pharmacist
Mayo Clinic
Department of Pharmacy
Jacksonville, Florida
Cesar A. Keller, MD
Professor of Medicine
Medical Director, Lung Transplant Program
Mayo Clinic
Jacksonville, Florida
A. Scott Mathis, PharmD
Director of Pharmacy
Monmouth Medical Center
Long Branch, New Jersey
Activity Overview
This supplement to The American Journal of Managed Care is intended to provide an understanding of solid organ transplantation as it relates to improving long-term graft survival. Included are the most recent data on transplant types and their outcomes, approaches to managing immunosuppression and its adverse effects, data on cost-effectiveness of transplantation, and strategies to improve adherence.
Educational Objectives
Upon completion of this activity, participants should be able to:
Intended Audience
Managed care clinicians and administrators, including physicians, pharmacists, medical and formulary directors, and other managed care professionals involved in the management and care of patients who have received an organ transplant.
Release date: January 15, 2015
Expiration date: January 15, 2016
Estimated time to complete activity: 3.0 hours
Type of activity: Knowledge
Fee: Free
Physician Credit
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accredita­ tion Council for Continuing Medical Education (ACCME) through the joint providership of the Penn State College of Medicine and Pharmacy Times Office of Continuing Professional Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Penn State College of Medicine designates this enduring material activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs) under the ACPE universal activity number 0290-9999-15-002-H01-P. The activity is available for CE credit through January 15, 2016.
Important Instructions for Obtaining CPE Credit:
To receive a Statement of Credit, participants must complete the pretest, read the article in its entirety and complete the online evaluation and post-test with a score of 70% or better. After successful completion and submission of the online posttest and activity evaluation your credit will be uploaded to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net..
NOTE: All steps must be completed in order to receive credit. Please ensure your Pharmacy Times account is updated with your NABP e-profile number and your date of birth (MMDD format). Participation data will not be uploaded into CPE MonitorTM if you do not have your NABP e-profile number and date of birth entered into your profile on www.pharmacytimes.org.
For Physician credit (CME) only
Physicians Only
For Pharmacy credit (CPE) only
Pharmacists Only
System Requirements
PC-based participants
Required: Windows® 7, Vista, XP, 2003 Server or 2000
Macintosh®-based participants
Required: Mac OS® X 10.4.11 (Tiger®) or newer
For questions about this Internet CPE activity, please contact: ceinfo@pharmacytimes.com.
Privacy Policy and Terms of Use Information: www.pharmacytimes.com/terms_condition.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More